Strategic Acquisition Advances Regenerative Medicine

Instron, a leading provider of testing equipment solutions designed to evaluate mechanical properties of materials and components, is pleased to announce the acquisition of Tissue Growth Technologies (TGT), a premier supplier of commercial bioreactors to grow and stimulate developing tissues.

TGT will become part of the Instron division of ITWs Test and Measurement business. In partnership, we are excited to offer an instrumentation platform that is uniquely designed to cater to all aspects of tissue engineering. Our broad range of applications include:

condition and engineer developing tissues characterize tissue engineering components reveal fundamental mechanisms of cell function direct stem cell differentiation provide an in vitro testbed for drug and cell therapy development

Instron and TGT are excited about this new partnership. Not only is Instron gaining the knowledge and experience of TGT, but were now able to provide a full range of solutions for the tissue engineering and regenerative medicine fields, said James Ritchey, Instrons Director of Tissue Engineering Businesses.

About Instron

Instron is a leading provider of test equipment for the material and structural testing markets. A global company providing single-source convenience, Instron manufactures and services products used to test the mechanical properties and performances of various materials, components and structures in a wide array of environments.

Instron systems evaluate materials ranging from the most fragile filament to advanced high-strength alloys, providing customers with comprehensive solutions for all their research, quality and service-life testing requirements. Additionally, Instron offers a broad range of service capabilities, including assistance with laboratory management, calibration expertise and customer training.

For more information, contact Instron, 825 University Ave, Norwood, MA 02062, USA. Toll-free: 1-800-564-8378; Fax: 1-781-575-5725; or visit our website at http://www.instron.com.

About Tissue Growth Technologies

Tissue Growth Technologies is a premier supplier of tissue engineering bioreactors and associated products specifically designed for the emerging regenerative medicine market. Building on 16 years of development, TGT has developed relationships with customers in corporate, academic, and government research across the globe. The teams experienced scientists and engineers are continually looking for opportunities to assist the tissue engineering and regenerative medicine market.

Read the original post:
Strategic Acquisition Advances Regenerative Medicine